Novel Techniques and Technology for Treatment of Brain Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (20 October 2022) | Viewed by 15093
Special Issue Editor
Special Issue Information
Dear Colleagues,
Advances in molecular biology, virtual reality, optical imaging, and intraoperative techniques have revolutionized the treatment of brain tumors. This Special Issue will describe a number of these technologies, including selective mitochondrial chemotherapy for glioblastoma and the oncomagnetic treatment of cancer with high-frequency alternating magnetic fields. The use of oncolytic viruses and gene-mediated cytotoxic immunotherapy for brain-tumor treatment will be discussed, including the use of polio virus and various adenoviruses. The status of stem-cell therapy for brain tumors will be presented. Operative advances including awake craniotomy with brain mapping, the use of three-dimensional virtual reality, nuances in endoscopic skull base surgery, and robotic neurosurgical techniques will be described.
Prof. Dr. David S. Baskin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumor
- glioblastoma
- immunotherapy
- surgery